Research Library

Decades of bad policy have heightened the risks of drug use and created barriers to treatment. And while some states are now trying to reduce the harms caused by the drug war, Texas is doubling down on ineffective policies.

Electronic waste is surging globally, presenting growing threats to the environment and human health. Rachel A. Meidl explains how coordinated action can help us move to a sustainable, circular economy of electronics.

This brief reviews federal and Texas specific policies and regulation to support the integration of non-medical services into health care payment systems.

Precision psychiatry promises to more accurately diagnose and treat patients. Brain health experts call for European researchers, policymakers and industry to work together to advance the field and give Europe a competitive edge.

Breathtaking AI advances necessitate a new suite of brain science-inspired policies to build brain capital.

In this report, fellow Tony Payan examines three recent U.S. criminal cases involving high-ranking Mexican officials. These cases point to a new “policy” by Washington to use its long-arm jurisdiction to arrest, prosecute and punish Mexican officials who have committed crimes that harm U.S. interests, he writes.

Despite the many potential challenges — including difficulties conserving water, using clean energy and dealing with the López Obrador administration — Tesla will most likely move forward with the construction of a “gigafactory" in Mexico. In this issue brief, fellow David Gantz explains why the benefits outweigh the risks.

The market for stem cell therapies is growing, but most of these treatments are still experimental — and patients who undergo them risk experiencing serious side effects. This quick take offers three recommendations to improve patient safety and education around stem cell interventions in Texas.

LOGINK offers Beijing a means to monitor and shape the international logistics market, increase foreign strategic dependency on China, and exploit the vulnerabilities of LOGINK users for economic and geostrategic purposes.

The rapid adoption of telemedicine is one of the few positive developments of the COVID-19 pandemic, writes fellow Katharine Neill Harris. She explains why the DEA’s recent proposal to change the rules for prescribing drugs via telemedicine would harm patients and increase demand for and exposure to unregulated and more dangerous drugs.